Published in:
01-12-2018 | Sleep Breathing Physiology and Disorders • Editorial
Drug-induced sleep endoscopy (DISE) as a guide towards upper airway behavior and treatment outcome: the quest for a vigorous standardization of DISE
Author:
Olivier M. Vanderveken
Published in:
Sleep and Breathing
|
Issue 4/2018
Login to get access
Excerpt
Since its first description in 1991 [
1], drug-induced sleep endoscopy or DISE has been progressively advocated as a useful assessment for patients with sleep-disordered breathing. A particular role for DISE has been to help determine the most suitable treatment option for the individual patient seeking an alternative for positive airway pressure (PAP) therapy [
2]. With the increased use of DISE in both clinical practice and research projects, the need for standardization of the technique has become collectively recognized [
3]. The need for standardization includes technical equipment and staffing, patient positioning and diagnostic maneuvers during DISE, drug usage, observation window, target events, and scoring and classification systems for DISE. These considerations have resulted in the publication of the “European position paper on DISE” in 2014 [
4], with an update that was recently published [
5]. This issue of the journal
Sleep and Breathing contains up to seven manuscripts that all address different aspects regarding DISE and its standardization in one of these perspectives. …